Higher serum iron may up liver cancer risk in NAFLD patients

(HealthDay)—Elevated serum iron and transferrin saturation levels are significantly associated with an increased risk for developing liver cancer in patients with nonalcoholic fatty liver disease (NAFLD), according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, held virtually from Nov. 12 to 15.,(HealthDay)—Elevated serum iron and transferrin saturation levels are significantly associated with an increased risk for developing liver cancer in patients with nonalcoholic fatty liver disease (NAFLD), according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, held virtually from Nov. 12 to 15.

Leave a Reply